Effect of Duloxetine 60 mg Versus Placebo in Patients With Chronic Low Back Pain in Japan
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2016
At a glance
- Drugs Duloxetine (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 30 Sep 2016 Results of subgroup analysis based on the number of painful body sites (n=456) presented at the 16th World Congress on Pain.
- 31 May 2016 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information JapicCTI132129).
- 21 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.